Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Metabolic and Tissue Repair Research
How Can I Learn More About Filing a Zepbound Lawsuit
Average Weight Loss in the Orforglipron phase 3 ATTAIN-1 Trial Across the 72-week study period, participants: Lost up to 15% of their body weight at the highest dose At 36 mg: 54.6% lost 10%, 36.0% lost 15%, 18.4% lost 20% body weight (all higher than placebo)
Comprehensive Wellness Approach: We integrate IV therapy with lifestyle recommendations for lasting benefits
What we monitor: Fasting glucose and insulin sensitivity markers are tracked before, during, and after your cycle
US$ 24.38
US$ 22.88
